Envestnet Asset Management
SCLN

Envestnet Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Envestnet Asset Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,474
Closed -$16K – 3183
2016
Q1 		$16K Buy
1,474
+79
+6% +$702 ﹤0.01% 2998
2015
Q4 		$13K Sell
1,395
-844
-38% -$7.07K ﹤0.01% 2931
2015
Q3 		$16K Buy
+2,239
New +$19.2K ﹤0.01% 2951

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Envestnet Asset Management's SCLN Position: Q2 2016 in Review

Envestnet Asset Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q2 2016, closing a stake of 1,474 shares — an estimated $16K sold.

Envestnet Asset Management first reported a position in SCLN in Q3 2015 and held it in 3 quarters. The position peaked at $16K in Q1 2016. 151 funds tracked by Wall St. Rank hold SCLN as of Q2 2016.

  • Envestnet Asset Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • Envestnet Asset Management sold 1,474 Sciclone Pharmaceuticals Inc shares in Q2 2016, an estimated $16K.
  • Envestnet Asset Management first reported a position in Sciclone Pharmaceuticals Inc in Q3 2015 and held it in 3 quarters.
  • Envestnet Asset Management's Sciclone Pharmaceuticals Inc position peaked at $16K in Q1 2016.
  • 151 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q2 2016.

Based on Envestnet Asset Management's 13F filing for Q2 2016, filed 15 Aug 2016.